Minimal change disease: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{Minimal change disease}} | {{Minimal change disease}} | ||
{{CMG}}; {{AE}} {{CZ}}, [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]] | {{CMG}}; {{AE}} {{CZ}}, [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]] | ||
{{SK}} Lipoid nephrosis, nil, nothing-in-light microscopy, steroid responsive nephrotic syndrome, steroid sensitive nephrotic syndrome | |||
==[[Minimal change disease overview|Overview]]== | ==[[Minimal change disease overview|Overview]]== |
Revision as of 20:44, 5 April 2015
For patient information, click here
Minimal Change Disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Minimal change disease On the Web |
American Roentgen Ray Society Images of Minimal change disease |
Risk calculators and risk factors for Minimal change disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Yazan Daaboul, Serge Korjian
Synonyms and keywords: Lipoid nephrosis, nil, nothing-in-light microscopy, steroid responsive nephrotic syndrome, steroid sensitive nephrotic syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Minimal change disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Immunohistology | Electron Microscopy | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Diet | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies